Literature DB >> 16114054

Growth, morphogenesis, and differentiation during mouse prostate development in situ, in renal grafts, and in vitro.

J D Doles1, C M Vezina, R J Lipinski, R E Peterson, W Bushman.   

Abstract

BACKGROUND: In vitro organ culture and renal grafting of the urogenital sinus (UGS) have both been used as models of prostate development. However, neither has been rigorously examined for its fidelity to replicate the canonical process of prostate differentiation in situ.
METHODS: We assessed size, morphology, histology, and the mRNA expression of differentiation marker genes of the E14 male mouse UGS grown for 0-28 days as sub-renal capsule allografts in nude mice or in culture containing androgen and compared these to UGS development in situ.
RESULTS: Development of grafted tissues was morphologically and histologically similar to development in situ but differentiation occurred more rapidly. UGS growth in organ culture resulted in bud formation, but did not trigger cellular differentiation. However, the potential for differentiation was maintained and could be rescued by grafting tissues into nude mice.
CONCLUSIONS: In vitro organ culture and renal grafting of UGS tissues may be appropriate models for studying prostatic bud formation, but only grafting is an appropriate model for prostatic differentiation. Copyright (c) 2005 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16114054     DOI: 10.1002/pros.20321

Source DB:  PubMed          Journal:  Prostate        ISSN: 0270-4137            Impact factor:   4.104


  22 in total

1.  Anchorage-independent culture maintains prostate stem cells.

Authors:  Xudong Shi; Jerry Gipp; Wade Bushman
Journal:  Dev Biol       Date:  2007-09-29       Impact factor: 3.582

2.  PI3K/mTOR signaling regulates prostatic branching morphogenesis.

Authors:  Susmita Ghosh; Hiu Lau; Brian W Simons; Jonathan D Powell; David J Meyers; Angelo M De Marzo; David M Berman; Tamara L Lotan
Journal:  Dev Biol       Date:  2011-10-08       Impact factor: 3.582

3.  RET-mediated glial cell line-derived neurotrophic factor signaling inhibits mouse prostate development.

Authors:  Hyun-Jung Park; Eric C Bolton
Journal:  Development       Date:  2017-05-15       Impact factor: 6.868

4.  DNA methylation of E-cadherin is a priming mechanism for prostate development.

Authors:  Kimberly P Keil; Lisa L Abler; Vatsal Mehta; Helene M Altmann; Jimena Laporta; Erin H Plisch; M Suresh; Laura L Hernandez; Chad M Vezina
Journal:  Dev Biol       Date:  2014-02-03       Impact factor: 3.582

5.  Visualization and quantification of mouse prostate development by in situ hybridization.

Authors:  Kimberly P Keil; Vatsal Mehta; Lisa L Abler; Pinak S Joshi; Christopher T Schmitz; Chad M Vezina
Journal:  Differentiation       Date:  2012-08-13       Impact factor: 3.880

6.  Histone acetylation regulates prostate ductal morphogenesis through a bone morphogenetic protein-dependent mechanism.

Authors:  Kimberly P Keil; Helene M Altmann; Lisa L Abler; Laura L Hernandez; Chad M Vezina
Journal:  Dev Dyn       Date:  2015-09-02       Impact factor: 3.780

7.  Wnt signaling though beta-catenin is required for prostate lineage specification.

Authors:  Brian W Simons; Paula J Hurley; Zhenhua Huang; Ashley E Ross; Rebecca Miller; Luigi Marchionni; David M Berman; Edward M Schaeffer
Journal:  Dev Biol       Date:  2012-08-30       Impact factor: 3.582

Review 8.  Recent advances in prostate development and links to prostatic diseases.

Authors:  Ginny L Powers; Paul C Marker
Journal:  Wiley Interdiscip Rev Syst Biol Med       Date:  2013-01-17

9.  Sonic hedgehog-responsive genes in the fetal prostate.

Authors:  Min Yu; Jerry Gipp; Joon Won Yoon; Phillip Iannaccone; David Walterhouse; Wade Bushman
Journal:  J Biol Chem       Date:  2008-12-18       Impact factor: 5.157

10.  Noggin is required for normal lobe patterning and ductal budding in the mouse prostate.

Authors:  Crist Cook; Chad M Vezina; Sarah H Allgeier; Aubie Shaw; Min Yu; Richard E Peterson; Wade Bushman
Journal:  Dev Biol       Date:  2007-09-29       Impact factor: 3.582

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.